ATE191221T1 - Steroid-sulfatase hemmende verbindungen - Google Patents
Steroid-sulfatase hemmende verbindungenInfo
- Publication number
- ATE191221T1 ATE191221T1 AT92918634T AT92918634T ATE191221T1 AT E191221 T1 ATE191221 T1 AT E191221T1 AT 92918634 T AT92918634 T AT 92918634T AT 92918634 T AT92918634 T AT 92918634T AT E191221 T1 ATE191221 T1 AT E191221T1
- Authority
- AT
- Austria
- Prior art keywords
- steroid sulfatase
- inhibiting compounds
- sulfatase inhibiting
- steroid
- compounds
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J51/00—Normal steroids with unmodified cyclopenta(a)hydrophenanthrene skeleton not provided for in groups C07J1/00 - C07J43/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
- C07J31/006—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring not covered by C07J31/003
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Steroid Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB919118465A GB9118465D0 (en) | 1991-08-29 | 1991-08-29 | Steroid sulphatase inhibitors |
PCT/GB1992/001586 WO1993005063A1 (en) | 1991-08-29 | 1992-08-28 | Steroid sulphatase inhibitors |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE191221T1 true ATE191221T1 (de) | 2000-04-15 |
Family
ID=10700597
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT92918634T ATE191221T1 (de) | 1991-08-29 | 1992-08-28 | Steroid-sulfatase hemmende verbindungen |
Country Status (8)
Country | Link |
---|---|
US (3) | US5604215A (de) |
EP (1) | EP0602123B1 (de) |
JP (2) | JP3583776B2 (de) |
AT (1) | ATE191221T1 (de) |
AU (1) | AU2494992A (de) |
DE (1) | DE69230857T2 (de) |
GB (1) | GB9118465D0 (de) |
WO (1) | WO1993005063A1 (de) |
Families Citing this family (43)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6476011B1 (en) | 1991-08-28 | 2002-11-05 | Sterix Limited | Methods for introducing an estrogenic compound |
GB9118478D0 (en) * | 1991-08-29 | 1991-10-16 | Imperial College | Steroid sulphatase inhibitors |
US6011024A (en) | 1991-08-28 | 2000-01-04 | Imperial College Of Science Technology & Medicine | Steroid sulphatase inhibitors |
US6903084B2 (en) | 1991-08-29 | 2005-06-07 | Sterix Limited | Steroid sulphatase inhibitors |
US5449712A (en) * | 1993-01-13 | 1995-09-12 | Thoro System Products, Inc. | Organosilicon emulsions for rendering porous substrates water repellent |
GB9422777D0 (en) * | 1994-11-11 | 1995-01-04 | Imperial College | Assay |
FR2730734B1 (fr) * | 1995-02-17 | 1997-03-28 | Rhone Poulenc Rorer Sa | Nouveaux composes manifestant des proprietes inhibitrices de farnesyl transferase et microorganisme du genre chrysosporium susceptible d'etre utilise pour les preparer |
AU7013296A (en) * | 1995-08-30 | 1997-03-19 | Eli Lilly And Company | N-butylsulfonate esters of estrogens |
US5705495A (en) * | 1995-10-19 | 1998-01-06 | Jenapharm Gmbh & Co. Kg. | Sulfamate derivatives of 1,3,5(10)-estratriene derivatives, methods for their production and pharmaceuticals containing these compounds |
US20040127473A1 (en) * | 1996-12-05 | 2004-07-01 | Reed Michael John | Compound |
US6642220B1 (en) | 1996-12-05 | 2003-11-04 | Sterix Limited | Compounds that inhibit oestrone sulphatase; compositions thereof; and methods employing the same |
US6288050B1 (en) | 1997-07-18 | 2001-09-11 | Duquesne University Of The Holy Ghost | Steroid sulfatase inhibitors and methods for making and using the same |
US6376687B1 (en) | 1997-07-18 | 2002-04-23 | Duquesne University Of The Holy Ghost | Steroid sulfatase inhibitors and methods for making and using the same |
GB2331987B (en) * | 1997-12-04 | 2002-11-27 | Imperial College | Polycyclic sulphamate inhibitors of oestrone sulphatase |
GB2331988B (en) | 1997-12-04 | 2003-04-16 | Imperial College | Polycyclic sulphamate inhibitors or oestrone sulphatase |
CA2330611A1 (en) | 1998-05-22 | 1999-12-02 | The Board Of Trustees Of The Leland Stanford Junior University | Bifunctional molecules and therapies based thereon |
US6248780B1 (en) | 1998-10-01 | 2001-06-19 | Duquesne University Of The Holy Ghost | Compounds for the treatment of estrogen-dependent illnesses and methods for making and using the same |
US6489369B1 (en) | 1999-02-03 | 2002-12-03 | Supergen, Inc. | Phosphocholine surfactants and their use |
JP2000309599A (ja) | 1999-04-13 | 2000-11-07 | Kyowa Hakko Kogyo Co Ltd | エストラ−1,3,5(10),16−テトラエン誘導体 |
JP5042411B2 (ja) | 1999-04-30 | 2012-10-03 | ステリックス リミテッド | 抗腫瘍剤としてのエストロン誘導体の使用 |
US7078395B1 (en) | 1999-06-16 | 2006-07-18 | Sterix Limited | Methods for treating or preventing cancer by preventing, inhibiting or arresting cell cycling |
GB9913536D0 (en) * | 1999-06-10 | 1999-08-11 | Sterix Ltd | Use |
DK1237902T3 (da) | 1999-12-13 | 2006-03-06 | Sterix Ltd | Halogenerede sulphamat-, fosfonat-, thiofosfonat-, sulfonat- og sulfonamidforbindelser som hæmmere af steroid sulfatase |
US7335650B2 (en) * | 2000-01-14 | 2008-02-26 | Sterix Limited | Composition |
AU2001248849A1 (en) * | 2000-04-24 | 2001-11-07 | Kyowa Hakko Kogyo Co. Ltd. | Estra-1,3,5(10)-triene derivatives |
GB0020498D0 (en) * | 2000-08-18 | 2000-10-11 | Sterix Ltd | Compound |
DE60234057D1 (de) | 2001-07-25 | 2009-11-26 | Raptor Pharmaceutical Inc | Zusammensetzungen und verfahren zur modulation des transports durch die blut-hirn-schranke |
WO2005020928A2 (en) | 2003-08-29 | 2005-03-10 | The Regents Of The University Of California | Agents and methods for enhancing bone formation by oxysterols in combination with bone morphogenic proteins |
GB0412492D0 (en) | 2004-06-04 | 2004-07-07 | Sterix Ltd | Compound |
EP1889198B1 (de) | 2005-04-28 | 2014-11-26 | Proteus Digital Health, Inc. | Pharma-informatiksystem |
US8030298B2 (en) | 2005-05-26 | 2011-10-04 | Abbott Products Gmbh | 17β-HSD1 and STS inhibitors |
GB0511190D0 (en) * | 2005-06-01 | 2005-07-06 | Sterix Ltd | Use |
JP2009508494A (ja) | 2005-09-16 | 2009-03-05 | ラプトール ファーマシューティカル インコーポレイテッド | Crを含むタンパク質に対して特異的な受容体−結合タンパク質(rap)変異体を含む組成物およびその使用 |
US9670244B2 (en) | 2006-02-27 | 2017-06-06 | The Regents Of The University Of California | Oxysterol compounds and the hedgehog pathway |
GB0604142D0 (en) | 2006-03-01 | 2006-04-12 | Sterix Ltd | Compound |
GB0624105D0 (en) * | 2006-12-01 | 2007-01-10 | Sterix Ltd | Use |
CA2698814A1 (en) | 2007-09-17 | 2009-03-26 | Preglem S.A. | Treatment of oestrogen dependant conditions in pre-menopausal women |
CN101951915A (zh) | 2007-12-03 | 2011-01-19 | 加利福尼亚大学董事会 | 用于刺猬蛋白信号、骨诱导、抗脂肪形成和wnt信号的激活的氧固醇 |
DK3395372T3 (da) | 2009-02-20 | 2022-04-19 | Enhanx Biopharm Inc | System til afgivelse af glutathion-baseret medikament |
EP2427178B1 (de) | 2009-05-06 | 2023-01-04 | Laboratory Skin Care, Inc. | Dermale freisetzungszusammensetzung mit wirkstoff-calciumphosphat-partikelkomplexen und anwendungsverfahren |
GB0914767D0 (en) | 2009-08-24 | 2009-09-30 | Sterix Ltd | Compound |
EP2847206A4 (de) | 2012-05-07 | 2016-01-20 | Univ California | Oxysterol-analogon oxy133 zur induktion von osteogenese und hedgehog-signalisierung sowie zur adipogenesehemmung |
CN105263500A (zh) | 2013-05-02 | 2016-01-20 | 加利福尼亚大学董事会 | 骨选择性成骨性氧固醇-骨靶向剂 |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE120016C (de) * | ||||
DE201143C (de) * | ||||
FR2133484A2 (en) * | 1969-04-29 | 1972-12-01 | Jenapharm Veb | 3-17 and 21-sulphonyloxy-steroids - with androgenic anabolic progestogenic and oestrogen activity of long duration |
DK127417B (da) * | 1969-11-21 | 1973-11-05 | Glaxo Lab Ltd | Fremgangsmåde til fremstilling af 9α- og/eller 9β-hydroxy-11β-nitrooxysteroider med aromatisk A-ring. |
BE779841R (en) * | 1972-02-25 | 1972-06-16 | Jenapharm Veb | Sulphonyloxy-13-beta-ethyl-gonanes - as oestrogenic-genic anti-fecundity and anti-lipaemic agents |
GB1398026A (en) * | 1972-11-10 | 1975-06-18 | Jenapharm Veb | Steroid esters |
DD120016A2 (de) * | 1975-02-17 | 1976-05-20 | ||
GB1527161A (en) * | 1976-02-19 | 1978-10-04 | Leo A | Enol esters of steroids |
DD201143B1 (de) * | 1981-11-17 | 1986-12-17 | Jenapharm Veb | Verfahren zur herstellung von 9,11-tritiummarkierten gonatriensulfonaten |
US4937237A (en) * | 1988-12-23 | 1990-06-26 | Smithkline Beckman Corporation | Phosphinic acid substituted aromatic steroids as inhibitors of steroid 5-60 -reductase |
GB9003939D0 (en) * | 1990-02-21 | 1990-04-18 | Imperial College | Sulphatase inhibitors |
US5177064A (en) * | 1990-07-13 | 1993-01-05 | University Of Florida | Targeted drug delivery via phosphonate derivatives |
-
1991
- 1991-08-29 GB GB919118465A patent/GB9118465D0/en active Pending
-
1992
- 1992-08-28 AT AT92918634T patent/ATE191221T1/de not_active IP Right Cessation
- 1992-08-28 EP EP92918634A patent/EP0602123B1/de not_active Expired - Lifetime
- 1992-08-28 JP JP50503193A patent/JP3583776B2/ja not_active Expired - Fee Related
- 1992-08-28 DE DE69230857T patent/DE69230857T2/de not_active Expired - Fee Related
- 1992-08-28 US US08/196,191 patent/US5604215A/en not_active Expired - Fee Related
- 1992-08-28 WO PCT/GB1992/001586 patent/WO1993005063A1/en active IP Right Grant
- 1992-08-28 AU AU24949/92A patent/AU2494992A/en not_active Abandoned
-
1995
- 1995-05-31 US US08/456,122 patent/US5861390A/en not_active Expired - Fee Related
-
1998
- 1998-03-20 US US09/044,984 patent/US6017904A/en not_active Expired - Fee Related
-
2001
- 2001-09-12 JP JP2001277335A patent/JP3786855B2/ja not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
JP3786855B2 (ja) | 2006-06-14 |
WO1993005063A1 (en) | 1993-03-18 |
JP3583776B2 (ja) | 2004-11-04 |
DE69230857T2 (de) | 2000-11-02 |
JPH07501514A (ja) | 1995-02-16 |
US5604215A (en) | 1997-02-18 |
EP0602123A1 (de) | 1994-06-22 |
JP2002145891A (ja) | 2002-05-22 |
EP0602123B1 (de) | 2000-03-29 |
US6017904A (en) | 2000-01-25 |
DE69230857D1 (de) | 2000-05-04 |
US5861390A (en) | 1999-01-19 |
AU2494992A (en) | 1993-04-05 |
GB9118465D0 (en) | 1991-10-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69230857T2 (de) | Steroid-Sulfatase hemmende Verbindungen | |
CY2394B1 (en) | Use of sulphamate derivatives as steroid sulphatase inhibitors. | |
NO944458D0 (no) | Hemmere av testosteron 5alfa-reduktaseaktivitet | |
MY110104A (en) | Saccharin derivative proteolytic enzyme inhibitors | |
EP1009755A4 (de) | Steroid sulfataseinhibitoren, verfahren zu ihrer herstellung und verwendung | |
NO931401D0 (no) | Steroidderivater for behandling av prostatahypertrofi, samt fremstilling og anvendelse derav | |
MX9708452A (es) | Inhibidores de sialidasa bacteriana y metodos para fabricar y usar la misma. | |
AU1345699A (en) | Steroid 3-o-sulphamate derivatives as inhibitors of oestrone sulphatase | |
NO983283L (no) | Hydrokamsyre-baserte Kollagenase-inhibitorer | |
DE69926078D1 (en) | Farnesyl-protein transferase inhibitoren | |
BG99313A (en) | 117-alkylketonesteroids as 5- -reductase inhibitors | |
NZ237559A (en) | Halogenoethyl steroid derivatives and pharmaceutical compositions | |
NO971196L (no) | Epimerer av (22RS)-N-(1,1,1-trifluor-2-fenylprop-2-yl)-3-okso-4-aza-5<alfa>-androst-1-en-17<beta>-karboksamid | |
MX9603476A (es) | Derivados de 11-(fenilo sustituido)-estra-4,9-dieno. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |